Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Calcium channel blockers（CCBs） are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
Global Calcium Channel Blocker key players include Pfizer, Aventis, Searle, Bayer, AstraZeneca, etc.
North America is the largest market, with a share about 30%, followed by Europe, and China, both have a share about 40 percent.
In terms of product, Amlodipine is the largest segment, with a share over 55%. And in terms of application, the largest application is Hypertension, followed by CHD, etc.
Market Analysis and Insights: Global Calcium Channel Blocker Market
In 2020, the global Calcium Channel Blocker market size was US$ 76 million and it is expected to reach US$ 84 million by the end of 2027, with a CAGR of 1.6% during 2021-2027.
Global Calcium Channel Blocker Scope and Market Size
Calcium Channel Blocker market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Calcium Channel Blocker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.
Segment by Type, the Calcium Channel Blocker market is segmented into
Dihydropyridine
Diltiazem
Verapamil
Others
Segment by Application, the Calcium Channel Blocker market is segmented into
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Calcium Channel Blocker market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Calcium Channel Blocker product introduction, recent developments, Calcium Channel Blocker sales by region, type, application and by sales channel.
The major companies include:
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
Global Calcium Channel Blocker key players include Pfizer, Aventis, Searle, Bayer, AstraZeneca, etc.
North America is the largest market, with a share about 30%, followed by Europe, and China, both have a share about 40 percent.
In terms of product, Amlodipine is the largest segment, with a share over 55%. And in terms of application, the largest application is Hypertension, followed by CHD, etc.
Market Analysis and Insights: Global Calcium Channel Blocker Market
In 2020, the global Calcium Channel Blocker market size was US$ 76 million and it is expected to reach US$ 84 million by the end of 2027, with a CAGR of 1.6% during 2021-2027.
Global Calcium Channel Blocker Scope and Market Size
Calcium Channel Blocker market is segmented by region, by country, company, type, application and by sales channels. Players, stakeholders, and other participants in the global Calcium Channel Blocker market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region, by country, company, type, application and by sales channels for the period 2016-2027.
Segment by Type, the Calcium Channel Blocker market is segmented into
Dihydropyridine
Diltiazem
Verapamil
Others
Segment by Application, the Calcium Channel Blocker market is segmented into
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
Regional and Country-level Analysis:
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Competitive Landscape
and Calcium Channel Blocker Market Share AnalysisCalcium Channel Blocker market competitive landscape provides details and data information by companies. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2016-2021. It also offers detailed analysis supported by reliable statistics on sale and revenue by players for the period 2016-2021. Details included are company description, major business, Calcium Channel Blocker product introduction, recent developments, Calcium Channel Blocker sales by region, type, application and by sales channel.
The major companies include:
Pfizer
Aventis
Searle
Bayer
AstraZeneca
Knoll Pharmaceuticals
Wyeth-Ayerst
AstraZeneca
Novartis
Sanofi
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
